Eli Samaha insider trades: Theravance Biopharma (TBPH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eli reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | TBPH | ↓ Sell | 6,964 | $17.14 | $119K | Indirect | Jul 8, 2026 (1d) |
| Jul 1, 2026 | TBPH | ↓ Sell | 336,697 | $17.20 | $5.8M | Indirect | Jul 1, 2026 (0d) |
| Jun 5, 2025 | STGW | ↑ Buy | 665,757 | $4.33 | $2.9M | Indirect | Jun 6, 2025 (1d) |
| May 9, 2025 | STGW | ↑ Buy | 200,903 | $4.76 | $956K | Indirect | May 13, 2025 (4d) |
| Aug 7, 2024 | TBPH | ↑ Buy | 999,800 | $7.80 | $7.8M | Indirect | Aug 9, 2024 (2d) |
| Jun 10, 2024 | SNV | ↓ Sell | 172,889 | $25.20 | $4.4M | Indirect | Jun 11, 2024 (1d) |
| Jun 7, 2024 | SNV | ↓ Sell | 7,148 | $25.22 | $180K | Indirect | Jun 7, 2024 (0d) |
| Jun 4, 2024 | SNV | ↓ Sell | 219,963 | $25.09 | $5.5M | Indirect | Jun 4, 2024 (0d) |
| May 1, 2024 | TBPH | ↑ Buy | 1,499,124 | $8.75 | $13.1M | Indirect | May 3, 2024 (2d) |
| Oct 20, 2023 | SNV | ↑ Buy | 560 | $21.35 | $12K | Indirect | Oct 24, 2023 (4d) |
| Oct 13, 2023 | SNV | ↑ Buy | 4,514 | $21.50 | $97K | Indirect | Oct 16, 2023 (3d) |
| Oct 11, 2023 | SNV | ↑ Buy | 2,910 | $21.38 | $62K | Indirect | Oct 11, 2023 (0d) |
| Oct 2, 2023 | SNV | ↑ Buy | 3,466 | $21.28 | $74K | Indirect | Oct 4, 2023 (2d) |
| Sep 27, 2023 | SNV | ↑ Buy | 12,196 | $21.30 | $260K | Indirect | Sep 28, 2023 (1d) |
| Sep 26, 2023 | SNV | ↑ Buy | 26,222 | $21.30 | $559K | Indirect | Sep 26, 2023 (0d) |
| Sep 21, 2023 | SNV | ↑ Buy | 243,014 | $21.39 | $5.2M | Indirect | Sep 21, 2023 (0d) |
| Mar 10, 2023 | STGW | ↑ Buy | 750,000 | $6.75 | $5.1M | Indirect | Mar 14, 2023 (4d) |
| Dec 29, 2022 | PFSW | ↓ Sell | 2,633,000 | $5.95 | $15.7M | Indirect | Dec 30, 2022 (1d) |
| Dec 29, 2022 | PFSW | ↑ Buy | 2,633,000 | $5.95 | $15.7M | Indirect | Dec 30, 2022 (1d) |
| Jun 24, 2022 | PFSW | ↑ Buy | 23,448 | $11.72 | $275K | Indirect | Jun 28, 2022 (4d) |
| May 12, 2022 | STGW | ↑ Buy | 644,452 | $6.90 | $4.4M | Indirect | May 12, 2022 (0d) |
| Apr 29, 2022 | PFSW | ↑ Buy | 63,190 | $11.23 | $710K | Indirect | Apr 29, 2022 (0d) |
| Apr 26, 2022 | PFSW | ↑ Buy | 85,600 | $11.15 | $954K | Indirect | Apr 26, 2022 (0d) |
| Apr 15, 2022 | PFSW | ↑ Buy | 13,507 | $11.79 | $159K | Indirect | Jun 17, 2022 (63d) |
| Dec 6, 2021 | STGW | ↑ Buy | 292,961 | $8.14 | $2.4M | Indirect | Dec 7, 2021 (1d) |
| Dec 2, 2021 | STGW | ↑ Buy | 450,000 | $7.65 | $3.4M | Indirect | Dec 2, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TBPH insiders
Open-market trades in the last 12 months
About Eli Samaha's insider trades
Eli Samaha is a 10% owner of Theravance Biopharma (TBPH). Since Dec 2, 2021, Eli has reported 20 open-market purchases worth $64.1M and 6 sales worth $31.6M on SEC Form 4. In the last 12 months: 2 sales ($5.9M).
Their filings also include grants and awards (16 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.